About
Technology
Issues
FAQ
Links
Official Page
Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.